CytoMed Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 4,988 | 0.0432% |
Public Companies | 1,336,923 | 11.6% |
Individual Insiders | 2,168,675 | 18.8% |
General Public | 3,375,797 | 29.3% |
Private Companies | 4,653,617 | 40.3% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
4,653,604 | US$9.4m | 0% | no data | |||
1,336,923 | US$2.7m | 0% | no data | |||
883,858 | US$1.8m | 0% | no data | |||
598,015 | US$1.2m | 0% | no data | |||
589,239 | US$1.2m | 0% | no data | |||
92,563 | US$187.9k | 0% | no data | |||
5,000 | US$10.2k | 0% | no data | |||
4,988 | US$10.1k | 92.1% | no data | |||
13 | US$25.8 | -98.5% | no data |